The number of deaths among patients with prostate tumors has tripled during the pandemic. These are the data of the health system in the UK.
Statistics show alarming changes in the diagnosis and treatment of prostate tumors during the pandemic. Judging by the sharp increase in the number of deaths, this disease began to be detected much later, when it is much less curable. Prostate cancer deaths among men have tripled during the pandemic, new data show.
Tea increases risk of prostate cancer – study
Prostate Cancer UK has conducted its most thorough analysis ever data from public hospitals and revealed very noticeable changes in the diagnosis and treatment of the insidious male disease. In general, doctors began to detect it much later, when the probability of beating cancer was lower. The overall death rate for men with prostate cancer has risen from 7% before the pandemic to 26% during the first 9 months of the fight against coronavirus, that is, more than tripled. But even in the next 9 months from January to September 2021, this figure was 18%, which is still much higher than the pre-pandemic level.
Irradiation for prostate cancer should be strong, but not for long
Researchers especially emphasize that the increased mortality of patients with prostate cancer was not provoked by the fact that they also suffered from COVID-19. Most often, the disease was detected in the elderly, and at this age the likelihood of its progression is higher. At the same time, the number of detected cases of advanced prostate tumors increased from 12.7% to 15.5% during the pandemic. (READ MORE)